98 related articles for article (PubMed ID: 26420019)
1. Arginine analogues incorporating carboxylate bioisosteric functions are micromolar inhibitors of human recombinant DDAH-1.
Tommasi S; Zanato C; Lewis BC; Nair PC; Dall'Angelo S; Zanda M; Mangoni AA
Org Biomol Chem; 2015 Dec; 13(46):11315-30. PubMed ID: 26420019
[TBL] [Abstract][Full Text] [Related]
2. S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase.
Leiper J; Murray-Rust J; McDonald N; Vallance P
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13527-32. PubMed ID: 12370443
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and Development.
Murphy RB; Tommasi S; Lewis BC; Mangoni AA
Molecules; 2016 May; 21(5):. PubMed ID: 27187323
[TBL] [Abstract][Full Text] [Related]
4. Designing modulators of dimethylarginine dimethylaminohydrolase (DDAH): a focus on selectivity over arginase.
Kotthaus J; Schade D; Kotthaus J; Clement B
J Enzyme Inhib Med Chem; 2012 Feb; 27(1):24-8. PubMed ID: 21740101
[TBL] [Abstract][Full Text] [Related]
5. GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA): evaluation of the importance of S-nitrosothiols as inhibitors of DDAH activity in vitro and in vivo in humans.
Chobanyan K; Thum T; Suchy MT; Zhu B; Mitschke A; Gutzki FM; Beckmann B; Stichtenoth DO; Tsikas D
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):32-41. PubMed ID: 17825631
[TBL] [Abstract][Full Text] [Related]
6. Structure of the mammalian NOS regulator dimethylarginine dimethylaminohydrolase: A basis for the design of specific inhibitors.
Frey D; Braun O; Briand C; Vasák M; Grütter MG
Structure; 2006 May; 14(5):901-11. PubMed ID: 16698551
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological activation of dimethylarginine dimethylaminohydrolase (DDAH) activity by inorganic nitrate and DDAH inhibition by N
Bollenbach A; Tsikas D
Amino Acids; 2019 Mar; 51(3):483-494. PubMed ID: 30536052
[TBL] [Abstract][Full Text] [Related]
8. Dimethylarginine-dimethylaminohydrolase-2 (DDAH-2) does not metabolize methylarginines.
Altmann KS; Havemeyer A; Beitz E; Clement B
Chembiochem; 2012 Nov; 13(17):2599-604. PubMed ID: 23125090
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship of novel and known inhibitors of human dimethylarginine dimethylaminohydrolase-1: alkenyl-amidines as new leads.
Kotthaus J; Schade D; Muschick N; Beitz E; Clement B
Bioorg Med Chem; 2008 Dec; 16(24):10205-9. PubMed ID: 19013076
[TBL] [Abstract][Full Text] [Related]
10. The DDAH/ADMA/NOS pathway.
Tran CT; Leiper JM; Vallance P
Atheroscler Suppl; 2003 Dec; 4(4):33-40. PubMed ID: 14664901
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons.
Selley ML
J Neurosci Res; 2004 Jul; 77(1):90-3. PubMed ID: 15197741
[TBL] [Abstract][Full Text] [Related]
12. Developing an irreversible inhibitor of human DDAH-1, an enzyme upregulated in melanoma.
Wang Y; Hu S; Gabisi AM; Er JA; Pope A; Burstein G; Schardon CL; Cardounel AJ; Ekmekcioglu S; Fast W
ChemMedChem; 2014 Apr; 9(4):792-7. PubMed ID: 24574257
[TBL] [Abstract][Full Text] [Related]
13. Regulation of fluid reabsorption in rat or mouse proximal renal tubules by asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase 1.
Bell T; Araujo M; Luo Z; Tomlinson J; Leiper J; Welch WJ; Wilcox CS
Am J Physiol Renal Physiol; 2018 Jul; 315(1):F74-F78. PubMed ID: 29513072
[TBL] [Abstract][Full Text] [Related]
14. Disruption of methylarginine metabolism impairs vascular homeostasis.
Leiper J; Nandi M; Torondel B; Murray-Rust J; Malaki M; O'Hara B; Rossiter S; Anthony S; Madhani M; Selwood D; Smith C; Wojciak-Stothard B; Rudiger A; Stidwill R; McDonald NQ; Vallance P
Nat Med; 2007 Feb; 13(2):198-203. PubMed ID: 17273169
[TBL] [Abstract][Full Text] [Related]
15. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
[TBL] [Abstract][Full Text] [Related]
16. The role of dimethylarginine dimethylaminohydrolase (DDAH) in pulmonary fibrosis.
Janssen W; Pullamsetti SS; Cooke J; Weissmann N; Guenther A; Schermuly RT
J Pathol; 2013 Jan; 229(2):242-9. PubMed ID: 23097221
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of 4-HNE mediated inhibition of hDDAH-1: implications in no regulation.
Forbes SP; Druhan LJ; Guzman JE; Parinandi N; Zhang L; Green-Church KB; Cardounel AJ
Biochemistry; 2008 Feb; 47(6):1819-26. PubMed ID: 18171027
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a transient covalent adduct formed during dimethylarginine dimethylaminohydrolase catalysis.
Stone EM; Person MD; Costello NJ; Fast W
Biochemistry; 2005 May; 44(18):7069-78. PubMed ID: 15865451
[TBL] [Abstract][Full Text] [Related]
19. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
Yamagishi S; Ueda S; Okuda S
Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
[TBL] [Abstract][Full Text] [Related]
20. An enzyme hydrolyzing methylated inhibitors of nitric oxide synthase is present in circulating human red blood cells.
Kang ES; Cates TB; Harper DN; Chiang TM; Myers LK; Acchiardo SR; Kimoto M
Free Radic Res; 2001 Dec; 35(6):693-707. PubMed ID: 11811522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
